MHRA phase I accreditation scheme

The microscopic bacteria living in women’s bodies could be a powerful tool for personalised, non-invasive treatment and earlier diagnosis.

Vaccination is one of the most effective and safest ways to protect against many serious infectious diseases

Summary of the latest safety advice for medicines and medical device users

The MHRA’s Interim Executive Director of Science and Research writes in The British Medical Journal on the approval of the UK’s first new UTI antibiotic in nearly 30 years, and the wider challenge of tackling antibiotic resistance.

Additional funding will allow the MHRA and NICE to continue developing clear, proportionate guidance for digital mental health technologies, supporting safer, more effective tools for people across the UK.

Guidance on labelling requirements pertinent to the type of medicinal product and its supply status, as defined in UK legislation.